Two Sigma Advisers’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$70.3K Buy
42,746
+3,646
+9% +$6K ﹤0.01% 2233
2025
Q1
$71.2K Buy
39,100
+2,200
+6% +$4K ﹤0.01% 2282
2024
Q4
$137K Buy
36,900
+11,300
+44% +$41.9K ﹤0.01% 2178
2024
Q3
$81.9K Sell
25,600
-79,300
-76% -$254K ﹤0.01% 2183
2024
Q2
$861K Buy
104,900
+10,500
+11% +$86.2K ﹤0.01% 1630
2024
Q1
$1.37M Buy
94,400
+46,300
+96% +$671K ﹤0.01% 1420
2023
Q4
$443K Sell
48,100
-12,300
-20% -$113K ﹤0.01% 1967
2023
Q3
$997K Sell
60,400
-156,500
-72% -$2.58M ﹤0.01% 1523
2023
Q2
$1.37M Sell
216,900
-422,700
-66% -$2.67M ﹤0.01% 1401
2023
Q1
$2.17M Sell
639,600
-8,200
-1% -$27.8K 0.01% 1235
2022
Q4
$3.74M Buy
647,800
+188,200
+41% +$1.09M 0.01% 902
2022
Q3
$4.32M Buy
459,600
+399,500
+665% +$3.76M 0.01% 804
2022
Q2
$1.34M Buy
+60,100
New +$1.34M ﹤0.01% 1442
2022
Q1
Sell
-18,600
Closed -$1.23M 2755
2021
Q4
$1.23M Buy
+18,600
New +$1.23M ﹤0.01% 1455
2020
Q3
Sell
-4,900
Closed -$343K 2421
2020
Q2
$343K Sell
4,900
-34,000
-87% -$2.38M ﹤0.01% 2060
2020
Q1
$1.36M Buy
38,900
+2,400
+7% +$83.9K 0.01% 1310
2019
Q4
$2.29M Buy
+36,500
New +$2.29M 0.01% 1161